AMT vs RGNX · P/E 31, rev $10.64B vs rev $114.4M
American Tower Corp (AMT) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the AMT and RGNX stock pages for the full models.
Not investment advice.